ACC 2019 preview – Bayer hopes for heart failure panache

ACC 2019 preview – Bayer hopes for heart failure panache

Source: 
EP Vantage
snippet: 

A Bayer heart failure project gets a high-profile unveiling, while Amarin and Esperion get a chance to reinforce their lipid-lowering candidates.